Stock Events

Stock Events

Illumin 

$0.56
133
+$0+0.89% Thursday 18:49

Statistics

Day High
0.58
Day Low
0.57
52W High
1.7
52W Low
0.55
Volume
2,000
Avg. Volume
14,096
Mkt Cap
29.23M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.08
-0.04
0.01
0.06
Expected EPS
-0.0503244
Actual EPS
N/A

Financials

0.54%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
198.93MRevenue
1.07MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ILLMF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap18.99B
Illumina, Inc. is a direct competitor in the genomic sequencing space, offering similar sequencing and array technologies.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific provides comprehensive solutions including instruments, reagents, and software for research, analysis, discovery, and diagnostics that compete with Illumin's offerings.
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Pacific Biosciences of California offers long-read sequencing technologies that compete with Illumin's short-read sequencing platforms.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories, Inc. offers a range of products for the life science research and clinical diagnostics markets, competing in the genomic and molecular diagnostics space.
Qiagen NV
QGEN
Mkt Cap10.16B
Qiagen N.V. provides sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the nucleic acid solutions market.
Agilent Technologies
A
Mkt Cap41.49B
Agilent Technologies, Inc. provides instruments, software, services, and consumables for the entire laboratory workflow, competing with Illumin in the genomics and molecular diagnostics sectors.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG offers diagnostic and research tools that compete with Illumin's genomic solutions, particularly in the sequencing and array-based technologies.
Quest Diagnostics
DGX
Mkt Cap19.57B
Quest Diagnostics incorporates genomic sequencing into its diagnostic testing services, competing indirectly with Illumin by offering similar diagnostic solutions.
Intellia Therapeutics
NTLA
Mkt Cap1.35B
Intellia Therapeutics, Inc. is involved in CRISPR/Cas9 technology, a gene editing technology that requires sequencing, indirectly competing with Illumin's sequencing technologies.
Editas Medicine
EDIT
Mkt Cap276.95M
Editas Medicine, Inc. also works in the gene editing space with CRISPR technology, relying on genomic sequencing technologies similar to those offered by Illumin for its research and development.

About

illumin Holdings Inc., a technology company, provides digital media solutions in the United States, Canada, Europe, Latin America, and internationally. The company offers a programmatic marketing platform that enables advertisers to connect with their audiences across online display, video, connected TV, social, and mobile campaigns. Its platform allows advertisers to manage their purchasing of online display advertising in real-time using programmatic ad buying. In addition, the company offers illumin platform, an advertising automation technology that provides planning, media buying, and omnichannel intelligence, as well as allows advertisers to map their consumer journey playbooks across screens and execute in real-time using programmatic technology. It serves Fortune 500 enterprises and small to mid-sized businesses. The company was formerly known as AcuityAds Holdings Inc. and changed its name to illumin Holdings Inc. in June 2023. illumin Holdings Inc. was founded in 2009 and is headquartered in Toronto, Canada.
Show more...
CEO
Mr. Simon Cairns
Country
CA
ISIN
CA45232V1067

Listings

TO
CA
ILLM.TO
OTC Link
US
ILLMF
F
DE
K3S0.F

0 Comments

Share your thoughts

FAQ

What is Illumin stock price today?▼
The current price of ILLMF is $0.56 USD — it has increased by +0.89% in the past 24 hours. Watch Illumin stock price performance more closely on the chart.
What is Illumin stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Illumin stocks are traded under the ticker ILLMF.
Is Illumin stock price growing?▼
ILLMF stock has fallen by -4.73% compared to the previous week, the month change is a -15.83% fall, over the last year Illumin has showed a -60.64% decrease.
What is Illumin market cap?▼
Today Illumin has the market capitalization of 29.23M
When is the next Illumin earnings date?▼
Illumin is going to release the next earnings report on May 07, 2026.
What were Illumin earnings last quarter?▼
ILLMF earnings for the last quarter are -0.07 USD per share, whereas the estimation was 0.01 USD resulting in a -700% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Illumin revenue for the last year?▼
Illumin revenue for the last year amounts to 198.93M USD.
What is Illumin net income for the last year?▼
ILLMF net income for the last year is 1.07M USD.
In which sector is Illumin located?▼
Illumin operates in the Communication Services sector.
When did Illumin complete a stock split?▼
Illumin has not had any recent stock splits.
Where is Illumin headquartered?▼
Illumin is headquartered in Toronto, CA.